MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation

a study on Heart Attack Heart Failure Heart Valve Disease Stable Angina Coronary Artery Disease Peripheral Artery Disease Heart Transplant Transplants

Summary

Eligibility
for people ages 18 years and up (full criteria)
Location
at San Francisco, California and other locations
Dates
study started
completion around
Principal Investigator
by Alexis Beatty, MD, MAS

Description

Summary

Cardiac rehabilitation is a medically recommended program for patients with certain heart conditions. It includes exercise training, health education, and counseling. Unfortunately, many patients do not participate in cardiac rehabilitation. Some find it challenging to attend the in-person sessions. This study aims to compare two methods of delivering cardiac rehabilitation: in-person and through telehealth. The investigators want to know if the effects of these two programs are alike and if certain individuals benefit more from one program over the other.

Keywords

Myocardial Infarction, Heart Failure, Systolic, Heart Valve Diseases, Angina, Stable, Coronary Artery Disease, Heart Transplant, cardiac rehabilitation, telehealth, Systolic Heart Failure, Stable Angina, Infarction, In-person cardiac rehabilitation, Telehealth cardiac rehabilitation

Eligibility

You can join if…

Open to people ages 18 years and up

  1. Age 18 or older
  2. Eligible for cardiac rehabilitation
    1. Diagnosis within 1 year prior to consent
    2. Chronic stable angina, or
    3. Chronic systolic heart failure (ejection fraction ≤ 35%)
    4. Referred to cardiac rehabilitation by a doctor or advanced practice provider for another indication that is covered by the participant's insurance, such as heart failure with preserved ejection fraction or aortic surgery.
  3. Willing to be randomized to in-person or telehealth cardiac rehabilitation
  4. Able to communicate in English or Spanish

You CAN'T join if...

  1. Unstable arrhythmias which may make unmonitored exercise unsafe (e.g., history of ventricular tachycardia not on medical therapy and without an implantable cardioverter defibrillator)
  2. Unsafe for patient to participate in the opinion of the investigator
  3. Hospice
  4. Unable to consent for self

Locations

  • UCSF accepting new patients
    San Francisco California 94143 United States
  • University of Michigan accepting new patients
    Ann Arbor Michigan 48105 United States
  • University of Pittsburgh Medical Center accepting new patients
    Pittsburgh Pennsylvania 15232 United States
  • Johns Hopkins University Medical Center accepting new patients
    Baltimore Maryland 21287 United States

Lead Scientist at UCSF

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
University of California, San Francisco
ID
NCT05933083
Study Type
Interventional
Participants
Expecting 516 study participants
Last Updated
Contact us about this trial